Sign in

CIK 0001839970 · <br>Emerging growth company

BlossomHill Therapeutics, Inc.

Sign in to watch
Ticker
BLSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851578711
Phone
858-732-3880
Business address
10255 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA
  1. 4 Open-market buy Director bought 625,000 shares at $16.00 ($10,000,000)
  2. 4 Open-market buy Director bought 625,000 shares at $16.00 ($10,000,000)
  3. 4 Open-market buy Director bought 6,000 shares at $16.00 ($96,000)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Director bought 312,500 shares at $16.00 ($5,000,000)
  6. 4 Conversion Director acquired 578,524 shares (conversion)
  7. 4 Open-market buy Chief Financial Officer bought 700 shares at $16.00 ($11,200)
  8. 4 Open-market buy General Counsel bought 4,700 shares at an average $15.89 ($74,700)
  9. 4 Derivatives Options or other derivatives
  10. 4 Conversion Executive Chairman acquired 1,838,896 shares (conversion)
  11. 4 Conversion President and CEO acquired 1,838,896 shares (conversion)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 22 filings